Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism — Stella

Home/Pulmonary Embolism/

View on ClinicalTrials.gov

Recruiting

Back to Pulmonary Embolism trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Czechia

University Hospital Kralovske Vinohrady, Prague

Key details

Phase

Post-approval study

Sponsor

Faculty Hospital Kralovske Vinohrady

Collaborators

Charles University, Czech Republic, University Hospital Ostrava

Enrollment target

~558 participants

Started

October 2022

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated November 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.